Back to Agenda
Session 9, Part I – Real World Evidence: The Building Blocks
Session Chair(s)
Mariette Boerstoel-Streefland, MD, MBA, MS
Senior Vice President, Worldwide Safety Officer
Bristol-Myers Squibb Company, United States
Session 9, Part I – Real World Evidence: The Building Blocks
Speaker(s)
PROTECT
Robert Reynolds, DrSc, MSc, FISPE
Pfizer Inc, United States
Vice President, Epidemiology, Worldwide Regulatory and Safety
FDA Sentinel Initiative: Status Update
Katrina Mott, MHS
FDA, United States
Partnerships Between Pharma and Database Owners
Andres Gomez, PhD, MPH
Bristol-Myers Squibb, United States
Vice President, Head of Epidemiology, Safety Science, and Analytics
Have an account?